Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid MalignanciesRomain Guièze, Catherine J. Wu, Vivian M. Liu et al.|Cancer Cell|2019Cited by 361
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara Gechijian, James E. Bradner, Georg E. Winter et al.|Nature Chemical Biology|2018Cited by 229
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcomeMatthew L. Hemming, James E. Bradner, Matthew A. Lawlor et al.|Proceedings of the National Academy of Sciences|2018Cited by 43